Technology

Arcturus Therapeutics Holdings

$67.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.09%) As of 3:16 PM UTC today

Why Robinhood?

You can buy or sell ARCT and other stocks, options, and ETFs commission-free!

About ARCT

Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA. The listed name for ARCT is Arcturus Therapeutics Holdings Inc. Common Stock.

CEO
Joseph E. Payne
Employees
—
Headquarters
San Diego, California
Founded
2013
Market Cap
1.83B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.03M
High Today
$69.17
Low Today
$66.51
Open Price
$67.00
Volume
211.63K
52 Week High
$129.71
52 Week Low
$8.51

Collections

ARCT Earnings

-$0.92
-$0.61
-$0.31
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

SLDB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure